Breast Cancer medicine pain reduced with 4300 IU vitamin D – RCT June 2012

Highlight from Vitamin D May Help Breast Cancer Survivors Stay on Track Medscape Medical News

2012 Annual Meeting of the American Society of Clinical Oncology®

• aromatase inhibitors
  half of the women have severe musculoskeletal pain from these agents, and 18% to 30% report fatigue, [resulting in] a discontinuation rate of about 10% each year,"
• 30,000 IU of oral vitamin D3 weekly on starting letrozole therapy achieved significant benefits in terms of fatigue, joint pain, and disability from joint pain.
• Using the Simple Descriptive Pain Intensity
  37% of women receiving vitamin D3
  51% of those in the placebo group
• adverse quality of life events = 42% vs 72%

---

Note: aromatase inhibitors reduction of bone causes pain

See also Vitamin D Life

• Overview Chronic Pain and Vitamin D
• All items in category Breast Cancer and Vitamin D
• Aromatase inhibitor chemotherapy after breast cancer not associated with vitamin D levels – Dec 2011
• Breast cancer survivors and vitamin D: A review PDF file
• Google search of Vitamin DWiki for Aromatase 111 items as of May 2015
• Vitamin D after breast cancer diagnosis
• All items in category Breast Cancer and Vitamin D 223 items
• Overview Breast Cancer and Vitamin D
• Breast Cancer aromatase therapy can cause sore tendons if low vitamin D – March 2015